Inhibrx Biosciences, Inc. (INBX): Eigentümerstruktur
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 266,667 US Dollar | 3 | 0 | 1 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 14.717.660 | 31,14 | 9,66 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Inhibrx Biosciences, Inc.
Mitarbeiter 109
Handelsplatz NASDAQ
Ticker Symbol INBX
IPO Datum 2024-05-29
Adresse 11025 North Torrey Pines Road, La Jolla, CA, United States, 92037
Webseite https://inhibrx.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Mr. Mark Paul Lappe | Founder, CEO & Chairman |
| 2 | Mr. David J. Matly M.B.A. | President |
| 3 | Ms. Kelly Devine Deck B.S., CPA, M.S. | Executive VP, CFO & Treasurer |
| 4 | Ms. Bonne Adams M.B.A. | Vice President of Operations |
| 5 | Ms. Kate Burke CPA, M.B.A. | Vice President of Accounting |
| 6 | Dr. Ashraf Amanullah Ph.D. | Executive VP & Chief Technical Operations Officer |
| 7 | Dr. Carlos Bais Ph.D. | EVP & Chief Scientific Officer |
| 8 | Ms. Leah Pollema J.D. | VP, General Counsel & Corporate Secretary |
| 9 | Dr. Josep Garcia Ph.D. | Executive VP & Chief Clinical Development Officer |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | Morgan Stanley - Brokerage Accounts | 8,89% | 0,12 Mrd. USD |
| 2 | Perceptive Advisors LLC | 8,82% | 0,12 Mrd. USD |
| 3 | Sanofi | 7,87% | 0,11 Mrd. USD |
| 4 | Viking Global Investors LP | 7,64% | 0,11 Mrd. USD |
| 5 | HighTower Advisors, LLC | 5,92% | 0,08 Mrd. USD |
| 6 | Bank of America Corp | 5,72% | 0,08 Mrd. USD |
| 7 | BlackRock Inc | 5,61% | 0,08 Mrd. USD |
| 8 | Schonfeld Strategic Advisors LLC | 4,74% | 0,07 Mrd. USD |
| 9 | State Street Corp | 4,35% | 0,06 Mrd. USD |
| 10 | Vanguard Capital Management, LLC | 3,35% | 0,05 Mrd. USD |
| 11 | Woodline Partners LP | 2,72% | 0,04 Mrd. USD |
| 12 | Capital Research Global Investors | 2,47% | 0,03 Mrd. USD |
| 13 | The Goldman Sachs Group Inc | 2,30% | 0,03 Mrd. USD |
| 14 | Partner Fund Management LP | 2,10% | 0,03 Mrd. USD |
| 15 | Sofinnova Ventures | 2,06% | 0,03 Mrd. USD |
| 16 | HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 1,85% | 0,03 Mrd. USD |
| 17 | Parkman Healthcare Partners LLC | 1,75% | 0,02 Mrd. USD |
| 18 | Geode Capital Management, LLC | 1,74% | 0,02 Mrd. USD |
| 19 | First Turn Management LLC | 1,12% | 0,02 Mrd. USD |
| 20 | Millennium Management LLC | 1,00% | 0,01 Mrd. USD |